Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Highly active antiretroviral therapy (HAART) is the current standard of care for human immunodeficiency virus (HIV) infections. Although drug resistance may have been present before the introduction of antiretroviral (ARV) therapy due to random genetic variation, the introduction of ARV therapy exerts selective pressure over viral subpopulations to develop resistance. The use of HAART decreases the risk of resistance when compared with mono or dual therapy regimens. However, drug resistance remains an undesirable outcome of long-term therapy.
Citation: https://www.omicsonline.org/hiv-antiretroviral-drug-resistance-2155-6113.S5-002.php?aid=4262
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi